n-acetyltalosaminuronic acid and Chronic Kidney Failure

n-acetyltalosaminuronic acid has been researched along with Chronic Kidney Failure in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Alloway, RR; Cafardi, J; Cardi, M; Cuffy, M; Dao, A; Diwan, T; Govil, A; Kaiser, TE; Loethen, A; Luckett, K; Rike, AH; Shah, SA; Sherman, KE; Woodle, ES	1

Other Studies

1 other study(ies) available for n-acetyltalosaminuronic acid and Chronic Kidney Failure

Article	Year
Use of HCV Ab+/NAT- donors in HCV naïve renal transplant recipients to expand the kidney donor pool. Clinical transplantation, 2019, Volume: 33, Issue:7 Topics: Adult; Donor Selection; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Hepacivirus; Hepatitis C; Hepatitis C Antibodies; Humans; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Prognosis; Risk Factors; Tissue and Organ Procurement; Tissue Donors; Transplant Recipients; Uronic Acids; Viral Load	2019

Article

Year

Use of HCV Ab+/NAT- donors in HCV naïve renal transplant recipients to expand the kidney donor pool.

Clinical transplantation, 2019, Volume: 33, Issue:7

Topics: Adult; Donor Selection; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Hepacivirus; Hepatitis C; Hepatitis C Antibodies; Humans; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Prognosis; Risk Factors; Tissue and Organ Procurement; Tissue Donors; Transplant Recipients; Uronic Acids; Viral Load

2019